Tracy Newbold

Director Técnico/Científico/I+D en LEXICON PHARMACEUTICALS, INC. .

Health Technology

Consumer Services

Cargos activos de Tracy Newbold

Empresas	Cargo	Inicio	Fin
LEXICON PHARMACEUTICALS, INC.	Director Técnico/Científico/I+D	01/07/2021	-

Empresas	Cargo	Inicio	Fin
Atox Bio Ltd. Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel.	Corporate Officer/Principal	01/01/2017	01/01/2020
UNITED THERAPEUTICS CORPORATION	Director de Operaciones	01/01/2011	01/01/2017
IMMUNOVANT, INC.	Director Técnico/Científico/I+D	01/02/2020	-

The University of North Carolina at Chapel Hill

Undergraduate Degree

Internacional

Estados Unidos	5
Israel	2

Operativa

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	1
Chief Operating Officer	1

Sectorial

Health Technology	5
Consumer Services	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	3
IMMUNOVANT, INC.	Health Technology
UNITED THERAPEUTICS CORPORATION	Health Technology
LEXICON PHARMACEUTICALS, INC.	Health Technology

Empresas privadas	1
Atox Bio Ltd. Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel.	Health Technology

Empresas privadas

Health Technology